Skip to main content
. 2022 Aug 29;5(8):e2228997. doi: 10.1001/jamanetworkopen.2022.28997

Figure 2. Monoclonal Antibody (mAb) Doses Administered After US Food and Drug Administration (FDA) Deauthorization, by State.

Figure 2.

A, Total number administered. B, Percentage of mAb supply administered.